The cancelation came as Moderna announced positive interim results from an early-stage trial of the vaccine that targeted H5 bird flu virus, …
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.